ATE213778T1 - Konstruktion von pasteurella haemolitika mutanten - Google Patents

Konstruktion von pasteurella haemolitika mutanten

Info

Publication number
ATE213778T1
ATE213778T1 AT95904281T AT95904281T ATE213778T1 AT E213778 T1 ATE213778 T1 AT E213778T1 AT 95904281 T AT95904281 T AT 95904281T AT 95904281 T AT95904281 T AT 95904281T AT E213778 T1 ATE213778 T1 AT E213778T1
Authority
AT
Austria
Prior art keywords
mutants
construction
haemolitika
pasteurella
methyltransferase
Prior art date
Application number
AT95904281T
Other languages
English (en)
Inventor
Robert E Briggs
Fred M Tatum
Original Assignee
Biotechnology And Res And Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology And Res And Dev filed Critical Biotechnology And Res And Dev
Application granted granted Critical
Publication of ATE213778T1 publication Critical patent/ATE213778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyurethanes Or Polyureas (AREA)
AT95904281T 1993-12-06 1994-12-06 Konstruktion von pasteurella haemolitika mutanten ATE213778T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/162,392 US5587305A (en) 1993-12-06 1993-12-06 Pasteurella haemolytica transformants
PCT/US1994/014095 WO1995016045A1 (en) 1993-12-06 1994-12-06 Construction of pasteurella heamolytica vaccines

Publications (1)

Publication Number Publication Date
ATE213778T1 true ATE213778T1 (de) 2002-03-15

Family

ID=22585422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904281T ATE213778T1 (de) 1993-12-06 1994-12-06 Konstruktion von pasteurella haemolitika mutanten

Country Status (8)

Country Link
US (6) US5587305A (de)
EP (2) EP0733114B1 (de)
AT (1) ATE213778T1 (de)
AU (1) AU692817B2 (de)
CA (1) CA2177734C (de)
DE (1) DE69430005T2 (de)
ES (1) ES2173170T3 (de)
WO (1) WO1995016045A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5840556A (en) * 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
AU767829B2 (en) * 1996-05-08 2003-11-27 Biotechnology Research And Development Corporation Molecular genetic constructions of vaccine strains of pasteurellaceae
US6770275B1 (en) * 1996-05-31 2004-08-03 Akzo Nobel N.V. Live attenuated RTC-producing bacteria of the family
FR2750704B1 (fr) * 1996-07-04 1998-09-25 Rhone Poulenc Rorer Sa Procede de production d'adn therapeutique
US6010705A (en) * 1997-04-11 2000-01-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Attenuated, invasive vaccines against fish pathogens
EP0973865A2 (de) * 1997-04-11 2000-01-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Abgeschwächte, invasive impfstoffe gegen fischpathogenen
WO1998046260A1 (en) * 1997-04-15 1998-10-22 Baylor College Of Medicine Pasteurella haemolytica vaccine
US7138384B1 (en) 1997-08-29 2006-11-21 The Regents Of The University Of California Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
ES2279582T3 (es) 1997-09-25 2007-08-16 Biotechnology Research And Development Corporation Mutante de delecion de lkta de p. hemolitica.
US6936262B2 (en) 1997-09-25 2005-08-30 Biotechnology Research And Development Corporation LktA deletion mutant of P. haemolytica
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
BR0009663A (pt) * 1999-04-09 2002-04-09 Upjohn Co Composições de vacinas antibacterianas
DE10046870A1 (de) * 2000-09-20 2002-03-28 Basf Ag Verfahren zur Veränderung des Genoms von Corynebakterien
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
US7521060B2 (en) * 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
AU2002342485A1 (en) * 2001-11-23 2003-06-10 Universite De Montreal Streptococcus suis avirulent vaccine and uses in antibiotic design
WO2003080149A2 (en) * 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US9528107B2 (en) * 2012-01-31 2016-12-27 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
BR112015010364B1 (pt) 2012-11-08 2022-05-03 Boehringer Ingelheim Animal Health USA Inc. Vacinas atenuadas de mannheimia haemolytica e métodos de produção e uso
WO2015066292A1 (en) 2013-11-01 2015-05-07 Merial Limited Attenuated pasteurella multocidavaccines & methods of making & use thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000412A1 (en) * 1978-08-24 1980-03-20 N Gilmour Pasteurellosis vaccines
US4388299A (en) * 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4335106A (en) * 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4837151A (en) * 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US5165924A (en) * 1986-01-22 1992-11-24 University Of Guelph Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle
US5055400A (en) * 1986-11-26 1991-10-08 University Of Guelph Leukotoxin gene of pasteurella haemolytica
US4957739A (en) * 1987-08-13 1990-09-18 Board Of Regents, The University Of Texas System Pharmaceutical compositions of a 105 kD P. Haemolytica derived antigen useful for treatment of Shipping Fever
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5468485A (en) * 1987-06-04 1995-11-21 Washington University Avirulent microbes and uses therefor
US4999191A (en) * 1988-05-05 1991-03-12 University Of Georgia Research Foundation, Inc. Pasteurella multocida vaccine
DE69027313T2 (de) * 1989-03-31 1997-01-23 Univ Washington Impfstoffe enthaltende avirulente phop-type mikroorganismen
CA2014033C (en) * 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
GB9100825D0 (en) * 1991-01-15 1991-02-27 Univ Guelph Pasteurella haemolytica glycoprotease gene and the purified enzyme

Also Published As

Publication number Publication date
DE69430005D1 (de) 2002-04-04
US5587305A (en) 1996-12-24
EP0733114B1 (de) 2002-02-27
US5824525A (en) 1998-10-20
AU1303195A (en) 1995-06-27
US5849305A (en) 1998-12-15
ES2173170T3 (es) 2002-10-16
US5733780A (en) 1998-03-31
US5693777A (en) 1997-12-02
AU692817B2 (en) 1998-06-18
US5683900A (en) 1997-11-04
WO1995016045A1 (en) 1995-06-15
CA2177734A1 (en) 1995-06-15
EP1149587A2 (de) 2001-10-31
EP1149587A3 (de) 2002-03-13
EP0733114A1 (de) 1996-09-25
DE69430005T2 (de) 2002-10-24
CA2177734C (en) 2011-06-21

Similar Documents

Publication Publication Date Title
DE69430005D1 (de) Konstruktion von pasteurella haemolitika mutanten
DE69106603D1 (de) Fluorhaltiges Copolymer und dieses enthaltende härtbare Zusammensetzung.
FI951538L (fi) Parannettu fysikaaliset ominaisuudet omaavat koostumukset, esineet ja menetelmät hapen poistamiseksi
NO944798L (no) Polysakkaridinneholdende fluider med ökt termisk stabilitet
DE69020858D1 (de) Hitzehärtbare Siloxanzusammensetzungen mit verlängerter Verarbeitungszeit.
AU3929485A (en) Biazxially oriented plastic container with heat-resistant and gas barrier properties
NO921926L (no) Broennsementsammensetninger med forbedrede egenskaper og fremgangsmaater ved anvendelse
NO930507D0 (no) Trokar med transparent kanyle samt fremgangsmaate ved anvendelse derav
DE3885920D1 (de) Vinylsilylalkoxy-arylbenzotriazol-Verbindungen und UV absorbierende Zusammensetzung mit ihnen.
KR940000028B1 (en) Text translation and correction system
DE3869924D1 (de) Hitze- und oelbestaendige kautschukmischung.
MX157573A (es) Mejoras en cierre para frascos y similares
EP0598552A3 (de) Härtbare, polymere Zusammensetzung.
BR9205464A (pt) Agente de reticulaçao e composiçao curavel
EP0444960A3 (en) Curable organopolysiloxane composition
NO893582D0 (no) Polymersammensetninger stabilisert med polysiloksaner.
DE3882781D1 (de) Impfstoff gegen pasteurella.
DE68921664D1 (de) Härtbare Polymer-Zusammensetzung.
NL9101936A (nl) Polymeermengsel en daaruit gevormde voorwerpen.
NO913814D0 (no) Innskudd av dna med modifiserte transposoner.
BR9100150A (pt) Recipiente com topo terminado em empena,processo para construcao do mesmo e aparelho para selar o recipiente
DE69108765D1 (de) Härtbare Organopolysiloxanzusammensetzung.
FI942249A0 (fi) Säteilykovettuva organopolysiloksaanikoostumus
FR2707297B1 (fr) Mélange silicone autoémulsifiable.
DE59001686D1 (de) Schutzbrille gegen gase.